Cargando…

Proto-oncogenic miR-744 is upregulated by transcription factor c-Jun via a promoter activation mechanism

Upregulation of miR-744 is associated with poor prognosis in many types of cancer patients, but it is still unclear how miR-744 becomes elevated in these tumors. In this study, we found that ectopic c-Jun elevated miR-744 expression, whereas c-Jun attenuation reduced miR-744 expression. Chromatin im...

Descripción completa

Detalles Bibliográficos
Autores principales: Sha, Zhou, Zhu, Xiaoxia, Li, Na, Li, Yiyi, Li, Dianhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323131/
https://www.ncbi.nlm.nih.gov/pubmed/27533465
http://dx.doi.org/10.18632/oncotarget.11285
_version_ 1782509972805910528
author Sha, Zhou
Zhu, Xiaoxia
Li, Na
Li, Yiyi
Li, Dianhe
author_facet Sha, Zhou
Zhu, Xiaoxia
Li, Na
Li, Yiyi
Li, Dianhe
author_sort Sha, Zhou
collection PubMed
description Upregulation of miR-744 is associated with poor prognosis in many types of cancer patients, but it is still unclear how miR-744 becomes elevated in these tumors. In this study, we found that ectopic c-Jun elevated miR-744 expression, whereas c-Jun attenuation reduced miR-744 expression. Chromatin immunoprecipitation assay confirmed the direct binding of c-Jun to the promoter of miR-744. The binding site of −343 to −349 bp within the most potential promoter like sequence of miR-744 was further validated by luciferase reporter gene assays. C-Jun-induced miR-744 upregulation could significantly promote migration and invasion of nasopharyngeal carcinoma cells and non-small cell lung cancer (NSCLC) cells, hence ectopic c-Jun was sufficient to rescue the migratory and invasive ability of these cells when miR-744 was knockdown. Additionally, a positive correlation between the expression levels of miR-744 and c-Jun was revealed in NSCLC samples with high (top 10%) level of miR-744 expression from the TCGA dataset. Taken together, our results demonstrated for the first time the regulatory mechanism of miR-744 transcription by c-Jun, providing a potential mechanism underlying the upregulation of miR-744 in cancers.
format Online
Article
Text
id pubmed-5323131
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-53231312017-03-23 Proto-oncogenic miR-744 is upregulated by transcription factor c-Jun via a promoter activation mechanism Sha, Zhou Zhu, Xiaoxia Li, Na Li, Yiyi Li, Dianhe Oncotarget Research Paper Upregulation of miR-744 is associated with poor prognosis in many types of cancer patients, but it is still unclear how miR-744 becomes elevated in these tumors. In this study, we found that ectopic c-Jun elevated miR-744 expression, whereas c-Jun attenuation reduced miR-744 expression. Chromatin immunoprecipitation assay confirmed the direct binding of c-Jun to the promoter of miR-744. The binding site of −343 to −349 bp within the most potential promoter like sequence of miR-744 was further validated by luciferase reporter gene assays. C-Jun-induced miR-744 upregulation could significantly promote migration and invasion of nasopharyngeal carcinoma cells and non-small cell lung cancer (NSCLC) cells, hence ectopic c-Jun was sufficient to rescue the migratory and invasive ability of these cells when miR-744 was knockdown. Additionally, a positive correlation between the expression levels of miR-744 and c-Jun was revealed in NSCLC samples with high (top 10%) level of miR-744 expression from the TCGA dataset. Taken together, our results demonstrated for the first time the regulatory mechanism of miR-744 transcription by c-Jun, providing a potential mechanism underlying the upregulation of miR-744 in cancers. Impact Journals LLC 2016-08-13 /pmc/articles/PMC5323131/ /pubmed/27533465 http://dx.doi.org/10.18632/oncotarget.11285 Text en Copyright: © 2016 Sha et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Sha, Zhou
Zhu, Xiaoxia
Li, Na
Li, Yiyi
Li, Dianhe
Proto-oncogenic miR-744 is upregulated by transcription factor c-Jun via a promoter activation mechanism
title Proto-oncogenic miR-744 is upregulated by transcription factor c-Jun via a promoter activation mechanism
title_full Proto-oncogenic miR-744 is upregulated by transcription factor c-Jun via a promoter activation mechanism
title_fullStr Proto-oncogenic miR-744 is upregulated by transcription factor c-Jun via a promoter activation mechanism
title_full_unstemmed Proto-oncogenic miR-744 is upregulated by transcription factor c-Jun via a promoter activation mechanism
title_short Proto-oncogenic miR-744 is upregulated by transcription factor c-Jun via a promoter activation mechanism
title_sort proto-oncogenic mir-744 is upregulated by transcription factor c-jun via a promoter activation mechanism
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323131/
https://www.ncbi.nlm.nih.gov/pubmed/27533465
http://dx.doi.org/10.18632/oncotarget.11285
work_keys_str_mv AT shazhou protooncogenicmir744isupregulatedbytranscriptionfactorcjunviaapromoteractivationmechanism
AT zhuxiaoxia protooncogenicmir744isupregulatedbytranscriptionfactorcjunviaapromoteractivationmechanism
AT lina protooncogenicmir744isupregulatedbytranscriptionfactorcjunviaapromoteractivationmechanism
AT liyiyi protooncogenicmir744isupregulatedbytranscriptionfactorcjunviaapromoteractivationmechanism
AT lidianhe protooncogenicmir744isupregulatedbytranscriptionfactorcjunviaapromoteractivationmechanism